Alexander Brehmer
Alexander Brehmer has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jan Egger
Institute for Artificial Intelligence in Medicine (IKIM), University Hospital Essen (AöR), Essen, Germany
3 shared publications - Jens Kleesiek
Technical University Dortmund
3 shared publications - Amir Abbas Mahabadi
University Hospital Essen, University of Duisburg-Essen, West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, Essen, Germany
1 shared publication - Benedikt Frank
Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, Essen, Germany
1 shared publication - Bernadette Hosters
Department Nursing Development and Nursing Research, University Hospital Essen, Essen, Germany
1 shared publication - Boris Hadaschik
Department of Urology, University Hospital Essen, 45147 Essen, Germany
1 shared publication
Latest Publications
- 15 August 2026
- Published by Springer Nature
- p. 441-452
On Effective Multi-class Skin Lesion Classification and Skin-Tone Bias Quantification
- 15 August 2026
- Published by Springer Nature
- p. 441-452
On Effective Multi-class Skin Lesion Classification and Skin-Tone Bias Quantification
- Open Access
- 1 May 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4 (1) , e67356
Fine-Grained Classification of Pressure Ulcers and Incontinence-Associated Dermatitis Using Multimodal Deep Learning: Algorithm Development and Validation Study
Background: Pressure ulcers (PUs) and incontinence-associated dermatitis (IAD) are prevalent conditions in clinical settings, posing significant challenges due to their similar presentations but differing treatment needs. Accurate differentiation between PUs and IAD is essential for appropriate patient care, yet it remains a burden for nursing staff and wound care experts. Objective: This study aims to develop and introduce a robust multimodal deep learning framework for the classification of PUs and IAD, along with the fine-grained categorization of their respective wound severities, to enhance diagnostic accuracy and support clinical decision-making. Methods: We collected and annotated a dataset of 1555 wound images, achieving consensus among 4 wound experts. Our framework integrates wound images with categorical patient data to improve classification performance. We evaluated 4 models—2 convolutional neural networks and 2 transformer-based architectures—each with approximately 25 million parameters. Various data preprocessing strategies, augmentation techniques, training methods (including multimodal data integration, synthetic data generation, and sampling), and postprocessing approaches (including ensembling and test-time augmentation) were systematically tested to optimize model performance. Results: The transformer-based TinyViT model achieved the highest performance in binary classification of PU and IAD, with an F1-score (harmonic mean of precision and recall) of 93.23%, outperforming wound care experts and nursing staff on the test dataset. In fine-grained classification of wound categories, the TinyViT model also performed best for PU categories with an F1-score of 75.43%, while ConvNeXtV2 showed superior performance in IAD category classification with an F1-score of 53.20%. Incorporating multimodal data improved performance in binary classification but had less impact on fine-grained categorization. Augmentation strategies and training techniques significantly influenced model performance, with ensembling enhancing accuracy across all tasks. Conclusions: Our multimodal deep learning framework effectively differentiates between PUs and IAD, achieving high accuracy and outperforming human wound care experts. By integrating wound images with categorical patient data, the model enhances diagnostic precision, offering a valuable decision-support tool for health care professionals. This advancement has the potential to reduce diagnostic uncertainty, optimize treatment pathways, and alleviate the burden on medical staff, leading to faster interventions and improved patient outcomes. The framework’s strong performance suggests practical applications in clinical settings, such as integration into hospital electronic health record systems or mobile applications for bedside diagnostics. Future work should focus on validating real-world implementation, expanding dataset diversity, and refining fine-grained classification capabilities to further enhance clinical utility.
- 1 May 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4 (1) , e67356
Open AccessFine-Grained Classification of Pressure Ulcers and Incontinence-Associated Dermatitis Using Multimodal Deep Learning: Algorithm Development and Validation Study
Background: Pressure ulcers (PUs) and incontinence-associated dermatitis (IAD) are prevalent conditions in clinical settings, posing significant challenges due to their similar presentations but differing treatment needs. Accurate differentiation between PUs and IAD is essential for appropriate patient care, yet it remains a burden for nursing staff and wound care experts. Objective: This study aims to develop and introduce a robust multimodal deep learning framework for the classification of PUs and IAD, along with the fine-grained categorization of their respective wound severities, to enhance diagnostic accuracy and support clinical decision-making. Methods: We collected and annotated a dataset of 1555 wound images, achieving consensus among 4 wound experts. Our framework integrates wound images with categorical patient data to improve classification performance. We evaluated 4 models—2 convolutional neural networks and 2 transformer-based architectures—each with approximately 25 million parameters. Various data preprocessing strategies, augmentation techniques, training methods (including multimodal data integration, synthetic data generation, and sampling), and postprocessing approaches (including ensembling and test-time augmentation) were systematically tested to optimize model performance. Results: The transformer-based TinyViT model achieved the highest performance in binary classification of PU and IAD, with an F1-score (harmonic mean of precision and recall) of 93.23%, outperforming wound care experts and nursing staff on the test dataset. In fine-grained classification of wound categories, the TinyViT model also performed best for PU categories with an F1-score of 75.43%, while ConvNeXtV2 showed superior performance in IAD category classification with an F1-score of 53.20%. Incorporating multimodal data improved performance in binary classification but had less impact on fine-grained categorization. Augmentation strategies and training techniques significantly influenced model performance, with ensembling enhancing accuracy across all tasks. Conclusions: Our multimodal deep learning framework effectively differentiates between PUs and IAD, achieving high accuracy and outperforming human wound care experts. By integrating wound images with categorical patient data, the model enhances diagnostic precision, offering a valuable decision-support tool for health care professionals. This advancement has the potential to reduce diagnostic uncertainty, optimize treatment pathways, and alleviate the burden on medical staff, leading to faster interventions and improved patient outcomes. The framework’s strong performance suggests practical applications in clinical settings, such as integration into hospital electronic health record systems or mobile applications for bedside diagnostics. Future work should focus on validating real-world implementation, expanding dataset diversity, and refining fine-grained classification capabilities to further enhance clinical utility.
- Open Access
- 31 October 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e55148
Establishing Medical Intelligence—Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management: Retrospective Cohort and Clinical Implementation Study
Background: FHIR (Fast Healthcare Interoperability Resources) has been proposed to enable health data interoperability. So far, its applicability has been demonstrated for selected research projects with limited data. Objective: This study aimed to design and implement a conceptual medical intelligence framework to leverage real-world care data for clinical decision-making. Methods: A Python package for the use of multimodal FHIR data (FHIRPACK [FHIR Python Analysis Conversion Kit]) was developed and pioneered in 5 real-world clinical use cases, that is, myocardial infarction, stroke, diabetes, sepsis, and prostate cancer. Patients were identified based on the ICD-10 (International Classification of Diseases, Tenth Revision) codes, and outcomes were derived from laboratory tests, prescriptions, procedures, and diagnostic reports. Results were provided as browser-based dashboards. Results: For 2022, a total of 1,302,988 patient encounters were analyzed. (1) Myocardial infarction: in 72.7% (261/359) of cases, medication regimens fulfilled guideline recommendations. (2) Stroke: out of 1277 patients, 165 received thrombolysis and 108 thrombectomy. (3) Diabetes: in 443,866 serum glucose and 16,180 glycated hemoglobin A1c measurements from 35,494 unique patients, the prevalence of dysglycemic findings was 39% (13,887/35,494). Among those with dysglycemia, diagnosis was coded in 44.2% (6138/13,887) of the patients. (4) Sepsis: In 1803 patients, Staphylococcus epidermidis was the primarily isolated pathogen (773/2672, 28.9%) and piperacillin and tazobactam was the primarily prescribed antibiotic (593/1593, 37.2%). (5) PC: out of 54, three patients who received radical prostatectomy were identified as cases with prostate-specific antigen persistence or biochemical recurrence. Conclusions: Leveraging FHIR data through large-scale analytics can enhance health care quality and improve patient outcomes across 5 clinical specialties. We identified (1) patients with sepsis requiring less broad antibiotic therapy, (2) patients with myocardial infarction who could benefit from statin and antiplatelet therapy, (3) patients who had a stroke with longer than recommended times to intervention, (4) patients with hyperglycemia who could benefit from specialist referral, and (5) patients with PC with early increases in cancer markers.
- 31 October 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e55148
Open AccessEstablishing Medical Intelligence—Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management: Retrospective Cohort and Clinical Implementation Study
Background: FHIR (Fast Healthcare Interoperability Resources) has been proposed to enable health data interoperability. So far, its applicability has been demonstrated for selected research projects with limited data. Objective: This study aimed to design and implement a conceptual medical intelligence framework to leverage real-world care data for clinical decision-making. Methods: A Python package for the use of multimodal FHIR data (FHIRPACK [FHIR Python Analysis Conversion Kit]) was developed and pioneered in 5 real-world clinical use cases, that is, myocardial infarction, stroke, diabetes, sepsis, and prostate cancer. Patients were identified based on the ICD-10 (International Classification of Diseases, Tenth Revision) codes, and outcomes were derived from laboratory tests, prescriptions, procedures, and diagnostic reports. Results were provided as browser-based dashboards. Results: For 2022, a total of 1,302,988 patient encounters were analyzed. (1) Myocardial infarction: in 72.7% (261/359) of cases, medication regimens fulfilled guideline recommendations. (2) Stroke: out of 1277 patients, 165 received thrombolysis and 108 thrombectomy. (3) Diabetes: in 443,866 serum glucose and 16,180 glycated hemoglobin A1c measurements from 35,494 unique patients, the prevalence of dysglycemic findings was 39% (13,887/35,494). Among those with dysglycemia, diagnosis was coded in 44.2% (6138/13,887) of the patients. (4) Sepsis: In 1803 patients, Staphylococcus epidermidis was the primarily isolated pathogen (773/2672, 28.9%) and piperacillin and tazobactam was the primarily prescribed antibiotic (593/1593, 37.2%). (5) PC: out of 54, three patients who received radical prostatectomy were identified as cases with prostate-specific antigen persistence or biochemical recurrence. Conclusions: Leveraging FHIR data through large-scale analytics can enhance health care quality and improve patient outcomes across 5 clinical specialties. We identified (1) patients with sepsis requiring less broad antibiotic therapy, (2) patients with myocardial infarction who could benefit from statin and antiplatelet therapy, (3) patients who had a stroke with longer than recommended times to intervention, (4) patients with hyperglycemia who could benefit from specialist referral, and (5) patients with PC with early increases in cancer markers.